# Extension 2: Second Temporary Rule — DEA telemedicine controlled-substance prescribing flexibility -- extension history

For Extension 2: Second Temporary Rule, published is 10/10/2023; federal register citation is 88 FR 69879; document number is 2023-22406; flexibility extended through is December 31, 2024; expiry date this rule replaced is November 11, 2023, verified against its source on 2026-08-31.

- **Temporary rule:** Extension 2: Second Temporary Rule _(our reading, not quoted from the source)_
- **Published:** 10/10/2023 _(verified: appears in the quote below)_
- **Federal Register citation:** 88 FR 69879 _(verified: appears in the quote below)_
- **Document number:** 2023-22406 _(verified: appears in the quote below)_
- **Effective period as stated:** As of November 11, 2023, the end of the effective period for the temporary rule published at 88 FR 30037 on May 10, 2023, is extended from November 11, 2024, to December 31, 2024. This rule is effective November 11, 2023. _(verified: appears in its own passage below)_
- **Flexibility extended through:** December 31, 2024 _(verified: appears in its own passage below)_
- **Expiry date this rule replaced:** November 11, 2023 _(verified: appears in its own passage below)_

## What the source says

> A Rule by the Drug Enforcement Administration and the Health and Human Services Department on 10/10/2023 Published Document: 2023-22406 (88 FR 69879)

## Where each value comes from

This source states these in separate places, so each value is shown with the passage that states it.

### Effective period as stated

> DATES: As of November 11, 2023, the end of the effective period for the temporary rule published at 88 FR 30037 on May 10, 2023, is extended from November 11, 2024, to December 31, 2024. This rule is effective November 11, 2023.

### Flexibility extended through

> Paragraph (c) is amended to extend the COVID-19 telemedicine prescribing flexibilities from May 12, 2023 through December 31, 2024, provided all of the conditions listed in paragraph (e) are met.

### Expiry date this rule replaced

> Paragraph (a) is amended to state that the authorization granted in the amended paragraph (c) expires at the end of December 31, 2024, instead of November 11, 2023.

## Source

- https://www.federalregister.gov/documents/2023/10/10/2023-22406/second-temporary-extension-of-covid-19-telemedicine-flexibilities-for-prescription-of-controlled

Last verified: 2026-08-31. Review by: 2026-10-30.
Part of [DEA telemedicine controlled-substance prescribing flexibility -- extension history](https://referencesource.org/dea-telemedicine-prescribing-flexibility-extensions/).